4:01 PM
 | 
Nov 14, 2017
 |  BC Extra  |  Company News

FDA approves Abilify tablets with ingestible sensor

Late Monday, FDA approved Abilify MyCite, which combines the antipsychotic Abilify aripiprazole from Otsuka Pharmaceutical Co. Ltd. (Tokyo, Japan) with an ingestible sensor from Proteus Digital Health Inc. (Redwood City, Calif.) in a single tablet to digitally track if the medication has been taken. The product is the first FDA-approved digital medicine system.

Abilify...

Read the full 248 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >